You are now leaving GSK Malta Health Portal

You are about to leave a GSK Website. By clicking this link, you will be taken to an external website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on this site. If you do not wish to leave this website, click on “Go Back” below:

Continue

Go back

MLT_GIB/OTH/0007/17m
Date of preparation: March 2018

Twinrix licensed indication

Twinrix Adult is indicated for use in non-immune adults and adolescents 16 years of age and above who are at risk of both hepatitis A and hepatitis B infection. 1

Twinrix Paediatric is indicated for use in non-immune infants, children and adolescents from 1 year up to and including 15 years who are at risk of both hepatitis A and hepatitis B infection. 2

Please see the full Summary of Product Characteristics before prescribing Twinrix.

 

References:

  1. Twinrix Adult Summary of Product Characteristics, GlaxoSmithKline.
  2. Twinrix Paediatric Summary of Product Characteristics, GlaxoSmithKline.

Twinrix is a registered trademark of the GlaxoSmithKline Group of Companies